“A recently launched peer reviewed publication in Current Breast Cancer Reports which highlights Tigerlily’s Clinical Trial capabilities. Tigerlily believe that it is critical to engage all parts of the community and co-create with life science stakeholders to implement bold, innovative ideas to improve health outcomes to everyone.”

Patients Drive Authentic Trusted Solutions for Inclusive Clinical Trials. Curr Breast Cancer Rep (2024). https://doi.org/10.1007/s12609-024-00526-5″